Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy
PHASE1CompletedINTERVENTIONAL
Enrollment
25
Participants
Timeline
Start Date
September 30, 1994
Study Completion Date
July 31, 2000
Conditions
Neoplasms
Interventions
DRUG
paclitaxel
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001387 - Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy | Biotech Hunter | Biotech Hunter